Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-20-064385

Director acquired 7,522 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kiely John Director 2020-12-15 Option exercise +7,522 17,522 D
Derivatives
Kiely John Director 2020-12-15 Option exercise · Restricted Stock Units −7,522 0 D
Loading xslF345X03/doc4.xml…